Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye

JOURNAL ARTICLE published 9 November 2023 in Journal of Neuroscience and Neurological Disorders

Authors: Gupta Vinod Kumar